SART3 Antibody - N-terminal region
Artikelnummer:
ASB-ARP39128_T100
- Bilder (3)
| Artikelname: | SART3 Antibody - N-terminal region |
| Artikelnummer: | ASB-ARP39128_T100 |
| Hersteller Artikelnummer: | ARP39128_T100 |
| Alternativnummer: | ASB-ARP39128_T100-25UL,ASB-ARP39128_T100-100UL |
| Hersteller: | Aviva |
| Wirt: | Rabbit |
| Kategorie: | Proteine/Peptide |
| Applikation: | IHC, WB |
| Spezies Reaktivität: | Canine, Equine, Guinea pig, Human, Porcine, Rat |
| Immunogen: | The immunogen is a synthetic peptide directed towards the N terminal region of human SART3 |
| Alternative Synonym: | P100, p110, DSAP1, TIP110, p110(nrb), RP11-13G14 |
| SART3 is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. SART3 is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This protein is thought to be involved in the regulation of mRNA splicing. |
|
|
Human Liver |
|
|
WB Suggested Anti-SART3 Antibody Titration: 2.5ug/ml ELISA Titer: 1:62500 Positive Control: Jurkat cell lysateSART3 is strongly supported by BioGPS gene expression data to be expressed in Human Jurkat cells |
|
|
SART3 antibody - N-terminal region (ARP39128_T100) in Human Jurkat using Western Blot |
Produktgarantie und fachkundiger Support
